Changes in hippocampal GABABR1 subunit expression in Alzheimer's patients: Association with Braak staging

Acta Neuropathologica

Volumn 109, Issue 5, 2005, Pages 467-474

  Iwakiri, Masahiko ^a   Mizukami, Katsuyoshi ^a   Ikonomovic, Milos D ^b   Ishikawa, Masanori ^a   Hidaka, Shin ^a   Abrahamson, Eric E ^b   DeKosky, Steven T ^b   Asada, Takashi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; GABABreceptor; Hippocampus; Neurofibrillary tangles; Neuronal degeneration

Indexed keywords

GABA B RECEPTOR 1 PROTEIN; PROTEIN GBR1; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID B RECEPTOR; ADENOSINE TRIPHOSPHATASE; ATP7A PROTEIN, HUMAN; CATION TRANSPORT PROTEIN; GABA TYPE B RECEPTOR, SUBUNIT 1; HYBRID PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CADAVER; CELL COUNT; CELL LABELING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL CULTURE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NEUROTRANSMISSION; NISSL STAINING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; CLASSIFICATION; COMPARATIVE STUDY; DEMOGRAPHY; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; MIDDLE AGED; NERVE CELL; PATHOLOGY; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATASES; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CATION TRANSPORT PROTEINS; CELL COUNT; DEMOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEURONS; POSTMORTEM CHANGES; RECEPTORS, GABA-B; RECOMBINANT FUSION PROTEINS;

EID: 21344443306     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-005-0985-9     Document Type: Article

References (38)

1. Amaral DG, Insausti R (1990) Hippocampal formation. In: Paxinos G (ed) The human nervous system. Academic Press, New York, pp 711-756
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, D.C.
3. Armstrong DM, Ikonomovic MD, Sheffield R, Wenthold RJ (1994) AMPA-selective glutamate receptor subtype immunoreactivity in the entorhinal cortex of non-demented elderly and patients with Alzheimer's disease. Brain Res 639:207-216
4. Armstrong DM, Ikonomovic MD, Mizukami K, Mishizin A, Sheffield R, Wolfe BB (1998) Glutamatergic mechanisms in Alzheimer's disease. Advances in Neurodegenerative Disorder: In Marwah J, Teitelbaum H (eds) Alzheimer's and Aging, vol 2, Prominent Press, Scottsdale, pp 71-97
5. B receptor heterodimer-component localization in human brain. Mol Brain Res 77:111-124
6. B-mediated inhibition of rat hippocampal pyramidal neurons in vitro. Neuroscience 68:637-643
7. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239-259 1:STN:280:By2C3c7ntFw%3D
8. A receptor changes in Alzheimer's disease. Neurosci Lett 82:246-252
9. A receptors in Alzheimer's disease: A quantitative autoradiographic study. Neurology 37:1454-1459
10. Duvernoy HM (1998) The human hippocampus, 2nd edn. Springer, Berlin
11. Flood DG, Guarnaccia M, Coleman PD (1987) Dendritic extent in human CA2-3 hippocampal pyramidal neurons in normal aging and senile dementia. Brain Res 409:88-96
12. Hof PR (1996) Morphology and neurochemical characterics of the vulnerable neurons in brain aging and Alzheimer's disease. Eur Neurol 37:71-81
13. Ikonomovic DM, Mizukami K, Davies P, Hamilton RL, Sheffield R, Armstrong DM (1997) The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains. J Neuropathol Exp Neurol 56:1018-1027
14. Ikonomovic MD, Mizukami K, Warde D, Sheffield R, Hamilton R, Wenthold RJ, Armstrong DM (1999) Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease. Exp Neurol 160:194-204
15. Ikonomovic MD, Nocera R, Mizukami K, Armstrong DM (2000) Age-related loss of the AMPA receptor subunits GluR2/3 in the human nucleus basalis of Meynert. Exp Neurol 166:363-375
16. Jicha GA, Bozer R, Kazam IG, Davies P (1997) Alz-50 and MC1, a new monoclonal antibody raised to paired helical filaments, recognize confirmational epitopes on recombinant tau. J Neurosci Res 48:128-132
17. BR2. Nature 396:674-679 10.1038/25348
18. B-receptor subtypes assemble into functional heterometric complexs. Nature 396:683-687 10.1038/25360
19. + channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron 19:687-695 10.1016/S0896-6273(00)80381-5
20. A receptor channels. Annu Rev Neurosci17:569-602
21. McKhann G, Drachman D, Folstein M, Katzman, R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944 1:STN:280:BiuB2cnis1M%3D
22. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486 1:STN:280:By6C1cjitVc%3D
23. Mize RR (1994) Quantitative image analysis for immunocytochemistry and in situ hybridization. J Neurosci Methods 54:219-237
24. A receptor β2/3 subunits in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes. Exp Neurol 147:333-345
25. A receptor β2 and β3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology. Mol Brain Res 56:268-272
26. A receptor α1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes. Brain Res 799:148-155
27. B receptor in the hippocampus of subjects with schizophrenia. Neurosci Lett 283:101-104
28. Mizukami K, Ishikawa M, Hidaka S, Iwakiri M, Sasaki M, Iritani S (2002) Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain. Prog Neuropsychopharmacol Biol Psychiatry 26:393-396 10.1016/ S0278-5846(01)00247-0
29. A receptors. In: Enna SJ, Bowery NG (eds) GABA receptors, 2nd edn. Humana Press, Clifton, pp 11-36
30. Palmer AM, Gershon S (1990) Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic? FASEB J 4:2745-2752
31. B receptor-mediated inhibition of calcium currents and excitatory synaptic transmission in hippocampal neurons in vitro. Neuron 12:97-107
32. B agonists and serotonin in cultured hippocampal neurons. J Neurophysiol 71: 2570-2575
33. Rössler M, Zarski R, Bohl J, Ohm TG (2002) Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuropathol 103:363-369
34. Smolen AJ (1990) Image analytic techniques for quantification of immunohistochemical staining in the nervous system. In: Conn PM (ed) Methods in Neurosciences, vol 3. Academic Press, New York, pp 208-229
35. West MJ (1993). Regionally specific loss of neurons in the aging human hippocampus. Neurobiol Aging 14:287-293
36. B receptor. Nature 396:679-682 10.1038/25354
37. 2+ influx. J Physiol 485:649-657
38. BR1 receptor immunoreactivity. Brain Res 830:345-352